Patrick Lamy
Corporate Officer/Principal bij AKERO THERAPEUTICS, INC.
Vermogen: 351 530 $ op 30-04-2024
Profiel
Patrick Lamy's career history includes current and former positions as well as education.
Currently, he is the Senior Vice President-Commercial Strategy at Akero Therapeutics, Inc. Previously, he worked at Gilead Sciences, Inc. as the Head-Commercial Strategy & Banking from 2008 to 2018, and at Iovance Biotherapeutics, Inc. as the Vice President-Commercial from 2018 to 2021.
In terms of education, Mr. Lamy holds an MBA from the University of California, Berkeley, and an undergraduate degree from the University of California San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AKERO THERAPEUTICS, INC.
0.03% | 08-12-2023 | 18 570 ( 0.03% ) | 351 530 $ | 30-04-2024 |
Actieve functies van Patrick Lamy
| Bedrijven | Functie | Begin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2023 |
Eerdere bekende functies van Patrick Lamy
| Bedrijven | Functie | Einde |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-09-2018 |
Opleiding van Patrick Lamy
| University of California, Berkeley | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AKERO THERAPEUTICS, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
